EntryPoint Capital’s Apogee Therapeutics APGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,997	Closed	-$133K	–	876
2024 Q1	$133K	Buy	1,997 +617	+45%	+$41K	0.12%	279
2023 Q4	$38.6K	Buy	+1,380	New	+$38.6K	0.04%	841